alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
# C_2005181DE.01003001.xml

| 23.7.2005 | DE | Amtsblatt der Europäischen Union | C 181/30 |
| --- | --- | --- | --- |

23.7.2005

DE

Amtsblatt der Europäischen Union

C 181/30

---

Berichtigung der einheitlichen Anwendung der Kombinierten Nomenklatur (KN)

(Einreihung von Waren)

(
  Amtsblatt der Europäischen Gemeinschaften C 16 vom 19. Januar 2002
  )

(
  Amtsblatt der Europäischen Gemeinschaften C 16 vom 19. Januar 2002

(2005/C 181/07)

Seite 6, Kapitel 30, Zusätzliche Anmerkung 1:

anstatt:

anstatt:

| „1. | Pflanzliche Arzneizubereitungen sind Zubereitungen auf der Grundlage einer oder mehrerer aktiver Wirkstoffe, die aus einer Pflanze oder Teilen von Pflanzen z.B. durch Trocknen, Mahlen, Extraktion oder Reinigung hergestellt wurden.
  Ein aktiver Wirkstoff ist eine chemisch einheitliche Substanz, eine chemisch definierte Gruppe von Substanzen (z.B. Alkaloide, Polyphenole oder Anthocyanine) oder ein Pflanzenextrakt. Diese aktiven Substanzen müssen medizinische Eigenschaften zur Verhütung oder Behandlung von spezifischen Krankheiten, Leiden oder deren Symptomen haben.“ |
| --- | --- |

„1.

Pflanzliche Arzneizubereitungen sind Zubereitungen auf der Grundlage einer oder mehrerer aktiver Wirkstoffe, die aus einer Pflanze oder Teilen von Pflanzen z.B. durch Trocknen, Mahlen, Extraktion oder Reinigung hergestellt wurden.

Ein aktiver Wirkstoff ist eine chemisch einheitliche Substanz, eine chemisch definierte Gruppe von Substanzen (z.B. Alkaloide, Polyphenole oder Anthocyanine) oder ein Pflanzenextrakt. Diese aktiven Substanzen müssen medizinische Eigenschaften zur Verhütung oder Behandlung von spezifischen Krankheiten, Leiden oder deren Symptomen haben.“

muss es heißen:

muss es heißen:

| „1. | Pflanzliche Arzneizubereitungen sind Zubereitungen auf der Grundlage eines Wirkstoffs oder mehrerer Wirkstoffe, die aus einer Pflanze oder Teilen von Pflanzen z. B. durch Trocknen, Mahlen, Extraktion oder Reinigung hergestellt wurden.
  Ein Wirkstoff ist eine chemisch einheitliche Substanz, eine chemisch definierte Gruppe von Substanzen (z. B. Alkaloide, Polyphenole oder Anthocyanine) oder ein Pflanzenextrakt. Diese Wirkstoffe müssen medizinische Eigenschaften zur Verhütung oder Behandlung von spezifischen Krankheiten, Leiden oder deren Symptomen haben.“ |
| --- | --- |

„1.

Pflanzliche Arzneizubereitungen sind Zubereitungen auf der Grundlage eines Wirkstoffs oder mehrerer Wirkstoffe, die aus einer Pflanze oder Teilen von Pflanzen z. B. durch Trocknen, Mahlen, Extraktion oder Reinigung hergestellt wurden.

Ein Wirkstoff ist eine chemisch einheitliche Substanz, eine chemisch definierte Gruppe von Substanzen (z. B. Alkaloide, Polyphenole oder Anthocyanine) oder ein Pflanzenextrakt. Diese Wirkstoffe müssen medizinische Eigenschaften zur Verhütung oder Behandlung von spezifischen Krankheiten, Leiden oder deren Symptomen haben.“

---
**Exhibit 31.1****CERTIFICATIONS**I, Michael C. Mayer, certify that:     1) I have reviewed this quarterly report on Form 10-Q of Bank of Commerce Holdings (the“registrant”);     2) Based on my knowledge, this quarterly report does not contain any untrue statement of amaterial fact or omit to state a material fact necessary to make the statements made, in light ofthe circumstances under which such statements were made, not misleading with respect to the periodcovered by this annual report;     3) Based on my knowledge, the financial statements, and other financial information includedin this quarterly report, fairly present in all material respects the financial condition, resultsof operations and cash flows of the registrant as of, and for, the periods presented in thisquarterly report;     4) The registrant’s other certifying officer and I are responsible for establishing andmaintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and15d-15(e)) for the registrant and we have:a. Designed such disclosure controls and procedures, or caused such disclosure controls andprocedures to be designed under our supervisions, to ensure that material information relating tothe registrant, including its consolidated subsidiaries, is made known to us by others within thoseentities, particularly during the period in which this quarterly report is being prepared;b. Evaluated the effectiveness of the issuer’s disclosure controls and procedures andpresented in this report our conclusions about the effectiveness of the disclosure controls andprocedures as of the end of the period covered by this report based on such evaluation; andc. Disclosed in this report any change in the issuer’s internal control over financial reportingthat occurred during the issuer’s most recent fiscal quarter (the issuer’s fourth fiscal quarter inthe case of an annual report) that has materially affected, or is reasonably likely to materiallyaffect, the issuer’s internal control over financial reporting; and;5. The issuer’s other certifying officer(s) and I have disclosed, based on our most recentevaluation of internal control over financial reporting, to the issuer’s auditors and the auditcommittee of issuer’s board of directors (or persons performing the equivalent functions):a. All significant deficiencies and material weaknesses in the design or operation of internalcontrol over financial reporting which are reasonably likely to adversely affect the issuer’sability to record, process, summarize and report financial information; andb. Any fraud, whether or not material, that involves management or other employees who have asignificant role in the issuer’s internal control over financial reporting.*/s/*MICHAEL C. MAYERMichael C. Mayer
-----Original Message----- 

From: ctrolinger@imt.net [mailto:ctrolinger@imt.net] 

Sent: Saturday, April 24, 2010 9:55 PM 

To: EBSA, E-OHPSCA - EBSA 

Subject: Comment in support of RIN 1210-AB30 

April 24, 2010 

I am writing to support the interim final rule under the Paul Wellstone 

and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008 

(RIN 1210-AB30). 

I support the strong rule that would forbid insurance companies from 

charging higher copayments, deductibles, and other out-of-pocket 

expenses for mental health treatment than they would for other physical 

health care. Thank you for ensuring that mental health care and 

physical health care coverage are included in a single deductible. 

If Congress had passed a Single Payer bill this wouldn't be an issue! 

Sincerely, 

Charlotte Trolinger 

1006 E. Geyser 

Livingston, MT 59047
#### Anthony Clinchy, Appellant, *v.*Daniel D. Brown et al., as Executors of Rachael Clinchy, Deceased, Respondents.

*Clinchy*v. *Brown,*137 App. Div. 900, appeal dismissed.

(Argued May 31, 1910;

decided June 7, 1910.)

Motion to dismiss an appeal from a judgment of tlie Appellate Division of the Supreme Court in the second judicial department, entered April 12, 1910, affirming a judgment in favor of plaintiff entered upon the report of a referee appointed to determine the validity of a claim against the estate of the decedent for services alleged to have been rendered.

The motion was made upon the ground that the Court of Appeals had no jurisdiction to entertain the appeal.

*William EL. Good*for motion.

*William Ehrlich*opposed.

Motion granted and appeal dismissed, with costs and ten dollars costs of motion.
-----Original Message----- 

From: LLindgren@svtv.com [mailto:LLindgren@svtv.com] 

Sent: Saturday, April 24, 2010 6:11 PM 

To: EBSA, E-OHPSCA - EBSA 

Subject: Comment in support of RIN 1210-AB30 

April 24, 2010 

I am writing to support the interim final rule under the Paul Wellstone 

and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008 

(RIN 1210-AB30). 

I support the strong rule that would forbid insurance companies from 

charging higher copayments, deductibles, and other out-of-pocket 

expenses for mental health treatment than they would for other physical 

health care. Thank you for ensuring that mental health care and 

physical health care coverage are included in a single deductible. 

Sincerely, 

Rev. lance Lindgren 

210 West 3rd Street 

Mission Hill, SD 57046
From: randyhoepker@hotmail.com [mailto:randyhoepker@hotmail.com] 

Sent: Saturday, April 24, 2010 11:02 PM 

To: EBSA, E-OHPSCA - EBSA 

Subject: Comment in support of RIN 1210-AB30 

April 24, 2010 

I am writing to support the interim final rule under the Paul Wellstone 

and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008 

(RIN 1210-AB30). 

I support the strong rule that would forbid insurance companies from 

charging higher copayments, deductibles, and other out-of-pocket 

expenses for mental health treatment than they would for other physical 

health care. Thank you for ensuring that mental health care and 

physical health care coverage are included in a single deductible. 

I believe that all Americans should be charged the same no matter their 

pre-existing conditions. 

Sincerely, 

Randy Hoepker 

340 Lincoln Rd 

Canton, IL 61520
-----Original Message----- 

From: ronh@nexyzbb.ne.jp [mailto:ronh@nexyzbb.ne.jp] 

Sent: Saturday, April 24, 2010 6:06 PM 

To: EBSA, E-OHPSCA - EBSA 

Subject: Comment in support of RIN 1210-AB30 

April 24, 2010 

I am writing to support the interim final rule under the Paul Wellstone 

and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008 

(RIN 1210-AB30). 

I support the strong rule that would forbid insurance companies from 

charging higher copayments, deductibles, and other out-of-pocket 

expenses for mental health treatment than they would for other physical 

health care. Thank you for ensuring that mental health care and 

physical health care coverage are included in a single deductible. 

Sincerely, 

Hilary Hofbauer 

P.O. Box 10 

Muenster, TX 76252
```

[Congressional Bills 104th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1939 Introduced in House (IH)]

104th CONGRESS
  1st Session
                                H. R. 1939

      To amend the Federal Home Loan Bank Act to provide for the 
    representation of Guam and the Virgin Islands on the boards of 
         directors of the appropriate Federal home loan banks.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             June 27, 1995

  Mr. Underwood (for himself and Mr. Frazer) introduced the following 
  bill; which was referred to the Committee on Banking and Financial 
                                Services

_______________________________________________________________________

                                 A BILL

 
      To amend the Federal Home Loan Bank Act to provide for the 
    representation of Guam and the Virgin Islands on the boards of 
         directors of the appropriate Federal home loan banks.
    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. REPRESENTATION OF GUAM AND THE VIRGIN ISLANDS ON BOARDS OF 
              DIRECTORS OF APPROPRIATE FEDERAL HOME LOAN BANKS.

    Section 7(e) of the Federal Home Loan Bank Act (12 U.S.C. 1427(e)) 
is amended by striking the third sentence.

SEC. 2. IMMEDIATE APPOINTMENT OF ADDITIONAL DIRECTORS TO SERVE UNTIL 
              DIRECTORS FROM GUAM AND THE VIRGIN ISLANDS ARE ELECTED.

    (a) In General.--Notwithstanding any limitation contained in 
section 7 of the Federal Home Loan Bank Act on the number of elective 
directors on the board of directors of any Federal home loan bank, the 
Federal Housing Finance Board shall appoint--
            (1) an additional elective director to the board of 
        directors for the Federal home loan bank whose district 
        includes Guam to represent members (of such bank) which are 
        located in Guam; and
            (2) an additional elective director to the board of 
        directors for the Federal home loan bank whose district 
        includes the Virgin Islands to represent members (of such bank) 
        which are located in the Virgin Islands.
    (b) Term.--An elective member appointed under a paragraph of 
subsection (a) shall serve until an elective director who represents 
the members described in such paragraph is first elected, in accordance 
with section 7 of the Federal Home Loan Bank Act, to the board of 
directors of the bank referred to in such paragraph.
    (c) Vacancy.--Any vacancy in a position established under 
subsection (a) before the end of the term described in subsection (b) 
shall be filled in the manner in which the original appointment was 
made.
                                 <all>
```
CONSENT OF INDEPENDENT ACCOUNTANTS

The Board of Directors
Copley Pharmaceutical, Inc.


We consent  to  incorporation  by  reference  in  registration  statements  (No.
33-54707),  (No.  33-96122) and (No. 33-96122) and (No. 33-96118) on Form S-8 of
Copley  Pharmaceutical,  Inc. of our report dated January 27, 1999,  relating to
the consolidated balance sheets of Copley pharmaceutical,  Inc. and subsidiaries
as of December 31, 1998 and the related  consolidated  statements of operations,
shareholders' equity and cash flows for the years ended December 31, 1998, which
report  appears in the  December  31, 1998 annual  report on Form 10-K of Copley
Pharmaceutical, Inc.


/s/ PricewaterhouseCoopers LLP
Exhibit 32.2

# CERTIFICATION OF CHIEF
FINANCIAL OFFICER PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
(18 U.S.C. SECTION 1350)

I, Gregory A. Wells, certify,
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

To the best of my knowledge and
belief, the quarterly report on Form 10-Q filed with the Securities and Exchange
Commission on November 13, 2003, by NTS-Properties III (the Periodic Report)
fully complies with the requirements of Section 13(a) of the Securities Exchange Act of
1934, and the information contained in the Periodic Report fairly presents, in all
material respects, the financial condition and results of operations of NTS-Properties
III.

A signed original of this written
statement required by Section 906 has been provided to NTS-Properties III and will be
retained by NTS-Properties III and furnished to the Securities and Exchange Commission or
its staff upon request.

/s/ Gregory A. Wells

---

Chief Financial Officer
of NTS Capital Corporation,
General Partner of NTS-Properties Associates,
General Partner of NTS-Properties III

---
§ 67.250 General requirements. ( a ) A notice of claim of lien or supplemental instrument thereto submitted for filing and recording must meet all of the requirements of subpart O of this part.
( b ) An instrument assigning or amending a notice of claim of lien must recite information which clearly identifies the notice of claim of lien being assigned or amended. Such information will normally consist of the book and page where the notice of claim is recorded and the date and time of filing. If the submission of the assignment or amendment is contemporaneous with submission of the notice of claim of lien, the information should include the name of each original claimant, the date of the notice of claim, and the amount of the claim and other information to adequately identify the notice of claim of lien being assigned or amended.
EXHIBIT 32.1

                              O'HARA RESOURCES LTD.
                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                       AS ADOPTED PURSUANT TO SECTION 906
                        OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of O'Hara Resources LTD. (the "Company") on
Form 10-KSB for the period ending April 30, 2004, as filed with the Securities
and Exchange Commission on the date hereof (the "Report"), I, Robert Vrooman,
the Chairman, CEO and Chief Financial Officer and Director of the Company,
hereby certify, pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to ss. 906
of the Sarbanes-Oxley Act of 2002, that:

(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934; and

(2) the information contained in the Report fairly presents, in all material
respects, the financial condition and result of operations of the Company.


/s/ ROBERT VROOMAN
------------------------------------------
Robert Vrooman
Chairman, CEO and Chief Financial Officer
(Principal Accounting Officer) and Director
January 27, 2005

The foregoing certifications are made solely for the purpose of 18 U.S.C.
Section 1350, subject to the knowledge standard contained therein, and not for
any other purpose.
#### § 1584.109 [Reserved]
```

[Federal Register Volume 77, Number 32 (Thursday, February 16, 2012)]
[Notices]
[Page 9198]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-3593]

========================================================================
Notices
                                                Federal Register
________________________________________________________________________

This section of the FEDERAL REGISTER contains documents other than rules 
or proposed rules that are applicable to the public. Notices of hearings 
and investigations, committee meetings, agency decisions and rulings, 
delegations of authority, filing of petitions and applications and agency 
statements of organization and functions are examples of documents 
appearing in this section.

========================================================================


Federal Register / Vol. 77, No. 32 / Thursday, February 16, 2012 / 
Notices

[[Page 9198]]

AFRICAN DEVELOPMENT FOUNDATION

Board of Directors Meeting

    Time: Tuesday, February 28, 2012, 8:45 a.m. to 1 p.m.
    Place: African Development Foundation, Conference Room, 1400 I 
Street NW., Suite 1000, Washington, DC 20005.
    Date: Tuesday, February 28, 2012.
    Status:
    1. Open session, Tuesday, February 28, 2012, 8:45 a.m. to 11:45 
a.m.; and
    2. Closed session, Tuesday, February 28, 2012, 12 p.m. to 1 p.m.
    Due to security requirements and limited seating, all individuals 
wishing to attend the open session of the meeting must notify Sarah 
Conway at (202) 233-8811 or sconway@usadf.gov of your request to attend 
by 5 p.m. on Thursday, February 23, 2012.

Lloyd O. Pierson,
President & CEO, USADF.
[FR Doc. 2012-3593 Filed 2-15-12; 8:45 am]
BILLING CODE 6117-01-P
```
#### § 1244.8 Analysis of waybill data.

Users of the waybill sample when presenting waybill analysis before the Board shall ensure that the appropriate weighting factors are applied to account for the stratified sampling. See Statement 81-1 for guidelines for weighting waybill data and for computing sampling errors.

[46 FR 26784, May 15, 1981. Redesignated at 65 FR 37711, June 16, 2000]
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Judicial Conference of the United States

# AGENCY:

Judicial Conference of the United States, Advisory Committee on Rules of Bankruptcy Procedure.

# ACTION:

Notice of open meeting. 

# SUMMARY:

The Advisory Committee on Rules of Bankruptcy Procedure will hold a two-day meeting. The meeting will be open to public observation but not participation.

# DATES:

September 6-7, 2007.

*Time:*                         8:30 a.m. to 5 p.m.                    

# ADDRESSES:

Teton Mountain Lodge & Spa, 3385 West Village Drive, Teton Village, Wyoming 83025.

# FOR FURTHER INFORMATION CONTACT:

 John K. Rabiej, Chief, Rules Committee Support Office, Administrative Office of the United States Courts, Washington, DC 20544, telephone (202) 502-1820.

Dated: July 9, 2007.

James Ishida,

Senior Attorney Advisor, Rules Committee Support Office.

[FR Doc. 07-3471 Filed 7-16-07; 8:45 am]

BILLING CODE 2210-55-M
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from the
form 10-K for the period ended December 31, 1997 and is qualified in its
entirety by reference to such 10-K.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-START>                             JAN-01-1997
<PERIOD-END>                               DEC-31-1997
<CASH>                                          22,129
<SECURITIES>                                     2,648
<RECEIVABLES>                                   13,626
<ALLOWANCES>                                     1,018
<INVENTORY>                                      2,203
<CURRENT-ASSETS>                                50,348
<PP&E>                                          43,956
<DEPRECIATION>                                  33,515
<TOTAL-ASSETS>                                  74,786
<CURRENT-LIABILITIES>                            8,623
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         7,500
<OTHER-SE>                                      49,187
<TOTAL-LIABILITY-AND-EQUITY>                    74,786
<SALES>                                              0
<TOTAL-REVENUES>                                78,926
<CGS>                                                0
<TOTAL-COSTS>                                   83,335
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                   571
<INTEREST-EXPENSE>                                  11
<INCOME-PRETAX>                                    328
<INCOME-TAX>                                     7,778
<INCOME-CONTINUING>                            (7,855)
<DISCONTINUED>                                 (2,342)
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (10,197)
<EPS-PRIMARY>                                   (1.57)
<EPS-DILUTED>                                   (1.57)


</TABLE>
## D.4. California- Oregon Border

for 2006

1 

## IMPROVE Monitoring

for 2006 -2010 (Fine Mass)

2006 Data2 

## 20073 

## 20084 

## 20095 

## 2010
#### Patrick Masterson, *Respondent, v.*Francis J. Masterson (Defendant) and George and Lewis Schwartz, *Judgment Creditors, Appellants*.

Order affirmed, with ten dollars costs and printing disbursements.